Patents by Inventor S. K. Dash

S. K. Dash has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF PREVENTING, CONTROLLING AND AMELIORATING URINARY TRACT INFECTIONS AND SUPPORTING DIGESTIVE HEALTH BY USING A SYNERGISTIC CRANBERRY DERIVATIVE, A D-MANNOSE COMPOSITION AND A PROPRIETARY PROBIOTIC BLEND
    Publication number: 20140294790
    Abstract: A method and composition prevents, controls and ameliorates urinary tract infections caused by E. coli by administering a therapeutically effective amount of a human dietary supplement composition comprising a cranberry derivative or proanthocyanidin containing concentrate, D-mannose and a proprietary probiotic blend. The cranberry derivative or proanthocyanidin containing concentrate comprises from about one percent (1.0%) by weight to about 95 percent (95.0%) by weight on a dry weight basis. The composition is formulated for delivering a D-mannose unit dosage between about 0.5 to about 5.0 grams per dose. A proprietary probiotic blend is included to provide 5 billion CFU per dose.
    Type: Application
    Filed: June 19, 2014
    Publication date: October 2, 2014
    Inventors: JOHN A. MINATELLI, W. STEPHEN HILL, S.K. DASH
  • METHOD OF PREVENTING, CONTROLLING AND AMELIORATING URINARY TRACT INFECTIONS AND SUPPORTING DIGESTIVE HEALTH BY USING A SYNERGISTIC CRANBERRY DERIVATIVE, A D-MANNOSE COMPOSITION AND A PROPRIETARY PROBIOTIC BLEND
    Publication number: 20110064706
    Abstract: A method and composition prevents, controls and ameliorates urinary tract infections caused by E. coli by administering a therapeutically effective amount of a human dietary supplement composition comprising a cranberry derivative or proanthocyanidin containing concentrate, D-mannose and a proprietary probiotic blend. The cranberry derivative or proanthocyanidin containing concentrate comprises from about one percent (1.0%) by weight to about 95 percent (95.0%) by weight on a dry weight basis. The composition is formulated for delivering a D-mannose unit dosage between about 0.5 to about 5.0 grams per dose. A proprietary probiotic blend is included to provide 5 billion CFU per dose.
    Type: Application
    Filed: September 24, 2010
    Publication date: March 17, 2011
    Applicant: U.S. Nutraceuticals, LLC d/b/a Valensa International
    Inventors: John A. MINATELLI, W. Stephen Hill, S. K. Dash